Literature DB >> 1371582

Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

W Y Gao1, F S Han, C Storm, W Egan, Y C Cheng.   

Abstract

Phosphorothioate oligodeoxycytidine (S-dCn) was used as a model compound to examine the impact of the number of phosphorothioate linkages and their position on the inhibition of human DNA polymerases and RNase H in vitro. S-dCn with a chain length longer than 15 could inhibit human DNA polymerases and RNase H activities, in a linkage number-dependent manner. Longer oligomers were more potent inhibitors than shorter ones. Kinetic studies indicated that S-dC28 was a competitive inhibitor of DNA polymerase alpha and beta with respect to the DNA template, whereas it was a noncompetitive inhibitor of polymerases gamma and delta. S-dC28 was also a competitive inhibitor of RNase H1 and H2 with respect to RNA-DNA duplex. Susceptibility of these enzymes to inhibition by S-dC28 was in the order of delta approximately gamma greater than alpha greater than beta and RNase H1 greater than RNase H2. Structural-activity relationships were explored with a group of S-dC28 analogs that have phosphorothioate internucleotide linkages at various positions. The inhibitory effect depended on the total number of thioate linkages, rather than the position of the linkages within the oligomer or the chain length itself. No sequence specificity was found. In the presence of the complementary RNA, antisense phosphorothioates (S-oligos) exerted a biphasic effect on RNase H activity. At low concentrations S-oligos could enhance the cleavage of the RNA portion of S-oligo-RNA duplex, whereas at high concentrations (in excess of the complementary RNA) S-oligos could inhibit RNase H and protect the complementary RNA from degradation. Together, these results suggest that the non-sequence-specific inhibitory effect of S-oligos should be taken into consideration in designing antisense inhibitors. This inhibitory activity could be avoided by decreasing the number of phosphorothioate linkages at the backbone, and S-oligos of 15-20 residues are preferable in antisense molecule design.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371582

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  34 in total

Review 1.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

2.  RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).

Authors:  B Verbeure; E Lescrinier; J Wang; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

Review 3.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

4.  RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

Authors:  O Heidenreich; S Gryaznov; M Nerenberg
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

5.  Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.

Authors:  H J Andreyev; P J Ross; D Cunningham; P A Clarke
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

6.  The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in mice.

Authors:  Frans O The; Wouter J de Jonge; Roel J Bennink; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

7.  Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice.

Authors:  Tsuyoshi Yamamoto; Naoko Fujii; Hidenori Yasuhara; Shunsuke Wada; Fumito Wada; Naoya Shigesada; Mariko Harada-Shiba; Satoshi Obika
Journal:  Nucleic Acid Ther       Date:  2014-04-23       Impact factor: 5.486

8.  Use of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides.

Authors:  Q Xu; K Musier-Forsyth; R P Hammer; G Barany
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

9.  Evidence for a dual functional role of a conserved histidine in RNA·DNA heteroduplex cleavage by human RNase H1.

Authors:  Nageswara R Alla; Allen W Nicholson
Journal:  FEBS J       Date:  2012-11-09       Impact factor: 5.542

10.  Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.

Authors:  G Q Yao; S Grill; W Egan; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.